CBD Gaze

CBD Gaze appears to have been a small Puerto Rico-based CBD-focused retail or affiliate-marketing business rather than a biotech, pharmaceutical, or clinical-stage healthcare company. Publicly available evidence indicates it operated the website cbdgaze.com and promoted third-party CBD products through the Amazon Associates program. In May 2020, the U.S. FDA and FTC issued a joint warning letter to CBD Gaze regarding unapproved and misbranded COVID-19-related claims tied to products promoted on its site. There is no clear evidence of an R&D pipeline, proprietary drug candidates, clinical programs, or platform technology. The entity is best characterized as a consumer CBD marketing/sales business, and its current operating status appears inactive based on the limited public footprint available.